Back to search
Logopenic Variant Primary Progressive Aphasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Logopenic Variant Primary Progressive Aphasia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Logopenic Variant Primary Progressive Aphasia trials you may qualify forThe goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abiliti…
The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and qua…
AD afflicts over 5.5. million Americans and is one of the most expensive diseases worldwide. In AD the variant in which language functions are most affected are…
The purpose of this study is to determine how inflammation is related to other changes in the brain that occur during the progression of Alzheimer's disease. Th…
Primary Progressive Aphasia (PPA) is a progressive syndrome in the family of Alzheimer's disease and related disorders involving devastating language impairment…
Primary progressive aphasia (PPA) is a disorder characterized by gradual decline in speech-language ability caused by underlying neurodegenerative disease. PPA…